Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 21, 2022; 28(31): 4376-4389
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4376
Figure 7
Figure 7 Risk stratification ability of the nomogram was estimated by the Kaplan–Meier method and log-rank test in the training and validation cohorts. A and B: Kaplan–Meier curves between the low- and high-risk subgroups of overall survival in the training cohort (A) and validation cohort (B); C and D: Kaplan–Meier curves between the low- and high-risk subgroups of disease-free survival in the training cohort (C) and validation cohort (D). Patients with hepatocellular carcinoma in the training and validation cohorts were divided into low- and high-risk subgroups according to whether the total points of each patient were lower or higher than the median points of each cohort.